Comment

Comment by galimaufry

As I understand it the issue is

* Currently the US welfare agencies will provide ~any FDA-approved drug for someone with the illness for which the drug was approved

* In this case, they probably won't - in the worst case scenario it would double their spending on prescription drugs and seems unlikely to help anyone

* So this is going to sever the link between FDA approval and medicaid spending.

* Now you have an awkward situation where agencies that not really equipped to make judgements on dug effectiveness, and which are not insulated from politics, have to make those decisions.

This could all work out for the best in the long term but may also be very awkward in the short term.

parent galimaufry 5 years ago

No comments yet

Be the first to share your thoughts.

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton